In conjunction with surgery, radiotherapy, and chemotherapy, targeted therapy has emerged as a promising therapy for oral cancers, such as by targeting proteins that are overexpressed in cancer cells (e.g. EGFR and PD1; Li et al., 2022; Cheng et al., 2022; Cao et al., 2022). Here, EGFR is linked to cancer.